◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › HCA

HCA Healthcare, Inc. (HCA) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Facilities · DATA UPDATED 2026-07-13

HCA Healthcare, Inc. (HCA) operates in the Health Care Facilities industry and is headquartered in Nashville, United States with about 230,000 employees. Its market capitalization is roughly $85 billion. In the fiscal year ended 2025-12-31, HCA reported $75.6B in revenue and $6.8B in net income.

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.

Interactive charts & full statements → Open the HCA valuation workbench →

HCA Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$76.4B$75.6B$70.6B$65.0B$60.2B$58.8B$51.5B$51.3B$46.7B$43.6B$41.5B$39.7B$36.9B$34.2B$33.0B$32.5B$30.7B$30.1B$28.4B$26.9B$25.5B
Gross Profit$26.7B$31.4B$28.7B$25.6B$23.2B$22.5B$43.2B$42.9B$39.0B$36.3B$34.6B$33.0B$30.7B$28.2B$27.3B$24.5B$23.1B$25.2B$23.8B$22.5B$21.2B
Gross Margin %34.9%41.5%40.6%39.4%38.5%38.3%83.8%83.5%83.5%83.2%83.3%83.3%83.0%82.5%82.7%75.4%75.2%83.8%83.7%83.6%83.0%
Operating Income (EBIT)$12.0B$12.0B$10.5B$9.6B$9.1B$9.7B$7.3B$7.2B$6.6B$6.1B$6.2B$6.0B$5.6B$4.8B$4.8B$4.3B$4.2B$3.8B$2.9B$3.0B$2.8B
Operating Margin %15.7%15.8%14.9%14.8%15.0%16.5%14.1%14.1%14.2%13.9%14.9%15.0%15.1%14.0%14.6%13.4%13.6%12.7%10.3%11.0%11.1%
Net Income$6.8B$6.8B$5.8B$5.2B$5.6B$7.0B$3.8B$3.5B$3.8B$2.2B$2.9B$2.1B$1.9B$1.6B$1.6B$2.5B$1.2B$1.1B$673M$874M$1.0B
Net Margin %8.9%9.0%8.2%8.1%9.4%11.8%7.3%6.8%8.1%5.1%7.0%5.4%5.1%4.5%4.9%7.6%3.9%3.5%2.4%3.2%4.1%
EBITDA$15.7B$15.6B$13.9B$12.7B$13.3B$14.3B$9.7B$9.7B$9.4B$8.2B$8.5B$7.5B$7.0B$6.5B$6.4B$7.1B$5.7B$5.4B$4.6B$4.8B$4.0B
Earnings Per Share (EPS)$28.90$29.40$22.00$18.96$19.15$21.16$10.87$10.07$10.66$5.95$7.30$4.99$4.16$3.37$3.49$4.97$2.76$3.02$1.93$2.51$2.53
Shares Outstanding (M)227M231M262M276M295M329M345M348M355M372M396M427M450M462M459M496M437M349M349M349M410M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HCA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$19.1B$19.5B$19.2B$18.6B$18.3B$18.3B$17.5B$17.5B
Gross Profit$2.9B$8.2B$8.0B$7.6B$7.6B$7.6B$7.0B$7.2B
Gross Margin %15.0%41.9%41.8%41.0%41.3%41.4%39.9%41.0%
Operating Income (EBIT)$2.9B$3.2B$3.0B$3.0B$2.9B$2.8B$2.4B$2.7B
Operating Margin %15.0%16.3%15.5%16.0%15.6%15.6%13.8%15.6%
Net Income$1.6B$1.9B$1.6B$1.7B$1.6B$1.4B$1.3B$1.5B
Net Margin %8.5%9.6%8.6%8.9%8.8%7.9%7.3%8.3%
EBITDA$3.8B$4.2B$3.9B$3.8B$3.7B$3.5B$3.3B$3.6B
Earnings Per Share (EPS)$7.15$8.14$6.78$6.83$6.45$5.63$4.89$5.53
Shares Outstanding (M)227M231M242M242M249M255M260M264M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HCA Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$13.0B$12.6B$10.5B$9.4B$8.5B$9.0B$9.2B$7.6B$6.8B$5.4B$5.7B$4.7B$4.4B$3.7B$4.2B$3.9B$3.1B$2.7B$1.8B$1.4B$1.8B
Capital Expenditures (CapEx)$5.1B$4.9B$4.9B$4.7B$4.4B$3.6B$2.8B$4.2B$3.6B$3.0B$2.8B$2.4B$2.2B$1.9B$1.9B$1.7B$1.3B$1.3B$1.6B$1.4B$1.9B
Free Cash Flow (FCF)$7.9B$7.7B$5.6B$4.7B$4.1B$5.4B$6.4B$3.4B$3.2B$2.4B$2.9B$2.4B$2.3B$1.7B$2.3B$2.3B$1.8B$1.4B$197M($48M)($20M)
FCF Margin %10.4%10.2%8.0%7.2%6.9%9.2%12.4%6.7%6.8%5.5%7.0%5.9%6.2%5.1%7.0%6.9%5.7%4.8%0.7%-0.2%-0.1%
Dividends Paid$682M$679M$690M$661M$653M$624M$153M$550M$487M$448M$434M$495M$7M$16M$3.1B$31M$4.3B$496M$201M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HCA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$2.0B$2.4B$4.4B$4.2B$1.7B$2.6B$3.5B$2.0B
Capital Expenditures (CapEx)$1.1B$1.5B$1.3B$1.2B$991M$1.3B$1.2B$1.3B
Free Cash Flow (FCF)$895M$870M$3.1B$3.0B$660M$1.3B$2.3B$690M
FCF Margin %4.7%4.5%16.3%16.3%3.6%7.0%13.3%3.9%
Dividends Paid$183M$162M$166M$171M$180M$165M$169M$171M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HCA Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$61.5B$60.7B$59.5B$56.2B$52.4B$50.7B$47.5B$45.1B$39.2B$36.6B$33.8B$32.7B$31.2B$28.8B$28.1B$26.9B$23.9B$24.1B$24.3B$24.0B$23.7B
Cash & Cash Equivalents$940M$1.0B$1.9B$935M$908M$1.5B$1.8B$621M$502M$732M$646M$741M$566M$414M$705M$373M$411M$312M$465M$393M$634M
Total Liabilities$64.4B$63.5B$59.0B$55.2B$52.5B$49.3B$44.6B$45.6B$42.1B$41.6B$39.4B$38.8B$37.7B$35.8B$36.4B$33.9B$34.6B$32.1B$33.5B$33.6B$34.1B
Total Debt (Short + Long-Term)$48.0B$46.8B$43.4B$40.0B$38.4B$35.0B$31.4B$34.1B$32.8B$33.1B$31.4B$30.5B$29.6B$28.4B$28.9B$27.1B$28.2B$25.7B$27.0B$27.3B$28.4B
Total Shareholders' Equity($6.3B)($2.8B)$555M$1.1B($73M)$1.5B$2.9B($565M)($2.9B)($5.0B)($5.6B)($6.0B)($6.5B)($6.9B)($8.3B)($7.0B)($10.8B)($8.0B)($9.3B)($9.6B)($10.5B)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HCA viewer.

Other Companies in Health Care Facilities

← HBTAll stocksHCAC →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.